150 related articles for article (PubMed ID: 32960876)
1. Table: Correct Use of inhalers for COPD.
Med Lett Drugs Ther; 2020 Sep; 62(1606):e150-e154. PubMed ID: 32960876
[No Abstract] [Full Text] [Related]
2. Expanded table: Correct use of inhalers for asthma.
Med Lett Drugs Ther; 2020 Dec; 62(1613):e204-e208. PubMed ID: 33446624
[No Abstract] [Full Text] [Related]
3. Drugs for COPD.
Med Lett Drugs Ther; 2020 Sep; 62(1606):137-144. PubMed ID: 32960872
[No Abstract] [Full Text] [Related]
4. Comparison table: Inhaled long-acting bronchodilators for treatment of COPD.
Med Lett Drugs Ther; 2020 Sep; 62(1606):e146-e147. PubMed ID: 32960874
[No Abstract] [Full Text] [Related]
5. Expanded table: Some inhaled drugs for treatment of asthma.
Med Lett Drugs Ther; 2020 Dec; 62(1613):e200-e203. PubMed ID: 33446623
[No Abstract] [Full Text] [Related]
6. Drugs for asthma.
Med Lett Drugs Ther; 2020 Dec; 62(1613):193-200. PubMed ID: 33446622
[No Abstract] [Full Text] [Related]
7. Comparison table: Inhaled corticosteroids for treatment of COPD.
Med Lett Drugs Ther; 2020 Sep; 62(1606):e148-e149. PubMed ID: 32960875
[No Abstract] [Full Text] [Related]
8. Duaklir Pressair: another LAMA/LABA inhaler for COPD.
Med Lett Drugs Ther; 2019 Sep; 61(1581):149-151. PubMed ID: 31599867
[No Abstract] [Full Text] [Related]
9. Trelegy Ellipta--a three-drug inhaler for COPD.
Med Lett Drugs Ther; 2018 May; 60(1547):86-88. PubMed ID: 29913467
[No Abstract] [Full Text] [Related]
10. Comparison table: Inhaled short-acting bronchodilators for treatment of COPD.
Med Lett Drugs Ther; 2020 Sep; 62(1606):e144-e145. PubMed ID: 32960873
[No Abstract] [Full Text] [Related]
11. Revefenacin (Yupelri) for COPD.
Med Lett Drugs Ther; 2019 Jan; 61(1564):14-15. PubMed ID: 30856160
[No Abstract] [Full Text] [Related]
12. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.
Kankaanranta H; Harju T; Kilpeläinen M; Mazur W; Lehto JT; Katajisto M; Peisa T; Meinander T; Lehtimäki L
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):291-307. PubMed ID: 25515181
[TBL] [Abstract][Full Text] [Related]
13. The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
Beeh KM; Derom E; Echave-Sustaeta J; Grönke L; Hamilton A; Zhai D; Bjermer L
Int J Chron Obstruct Pulmon Dis; 2016; 11():193-205. PubMed ID: 26893551
[TBL] [Abstract][Full Text] [Related]
14. ▼Olodaterol--another LABA for COPD.
Drug Ther Bull; 2015 Apr; 53(4):42-5. PubMed ID: 25858815
[TBL] [Abstract][Full Text] [Related]
15. Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.
Sauer R; Hänsel M; Buhl R; Rubin RA; Frey M; Glaab T
Int J Chron Obstruct Pulmon Dis; 2016; 11():891-8. PubMed ID: 27217742
[TBL] [Abstract][Full Text] [Related]
16. Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial.
Ismaila AS; Birk R; Shah D; Zhang S; Brealey N; Risebrough NA; Tabberer M; Zhu CQ; Lipson DA
Adv Ther; 2017 Sep; 34(9):2163-2172. PubMed ID: 28875459
[TBL] [Abstract][Full Text] [Related]
17. In vitro dose comparison of Respimat
Ciciliani AM; Langguth P; Wachtel H
Int J Chron Obstruct Pulmon Dis; 2017; 12():1565-1577. PubMed ID: 28603412
[TBL] [Abstract][Full Text] [Related]
18. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease.
Cramer JA; Bradley-Kennedy C; Scalera A
Can Respir J; 2007; 14(1):25-9. PubMed ID: 17315055
[TBL] [Abstract][Full Text] [Related]
19. Tiotropium/olodaterol (Stiolto Respimat) for COPD.
Med Lett Drugs Ther; 2015 Nov; 57(1482):161-2. PubMed ID: 26583607
[No Abstract] [Full Text] [Related]
20. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.
Donohue JF; Kalberg C; Emmett A; Merchant K; Knobil K
Treat Respir Med; 2004; 3(3):173-81. PubMed ID: 15219176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]